Fusidic acid and clindamycin resistance in community-associated, methicillin-resistant Staphylococcus aureus infections in children of Central Greece

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Katopodis, George D ^a   Grivea, Ioanna N ^a   Tsantsaridou, Angeliki J ^a   Pournaras, Spyros ^a   Petinaki, Efi ^a   Syrogiannopoulos, George A ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; LINEZOLID; METICILLIN; OXACILLIN; PANTON VALENTINE LEUKOCIDIN; PSEUDOMONIC ACID; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CHILD HOSPITALIZATION; COMMUNICABLE DISEASE; CONTROLLED STUDY; DISK DIFFUSION; FEMALE; GENOTYPE PHENOTYPE CORRELATION; GREECE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NEWBORN; NONHUMAN; OUTPATIENT DEPARTMENT; PRESCHOOL CHILD; SCHOOL CHILD; SKIN INFECTION; SOFT TISSUE INFECTION; CLASSIFICATION; GENOTYPE; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PHENOTYPE; STAPHYLOCOCCUS INFECTION;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CLINDAMYCIN; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; FUSIDIC ACID; GENOTYPE; GREECE; HUMANS; INFANT; INFANT, NEWBORN; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; PHENOTYPE; STAPHYLOCOCCAL INFECTIONS;

EID: 78649918888     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-351     Document Type: Article

References (44)

1. CDC Methicillin-resistant Staphylococcus aureus: United States. MMWR 1981, 30:557-559. CDC.
2. CDC Four pediatric deaths from community-acquired methicillin resistant Staphylococcus aureus: Minnesota and North Dakota, 1997-1999. MMWR 1999, 48:707-710. CDC.
3. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy ME, Etienne J. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine Leukocidin genes: worldwide experience. Emerg Infect Dis 2003, 9:978-984.
4. Ellington MJ, Perry C, Ganner M, Warner M, McCormick Smith I, Hill RL, Shallcross L, Sabersheikh S, Holmes A, Cookson BD, Kearns AM. Clinical and molecular epidemiology of ciprofloxacin-susceptible MRSA encoding PVL in England and Wales. Eur J Clin Microbiol Infect Dis 2009, 28:1113-1121. 10.1007/s10096-009-0757-x, 19484277.
5. Antri K, Rouzic N, Dauwalder O, Boubekri I, Bes M, Lina G, Vandenesch F, Tazir M, Ramdani-Bouguessa N, Etienne J. High prevalence of MRSA clone ST80-IV in the hospital and community settings in Algiers. Clin Microbiol Infect 2010,
6. Dufour P, Gillet Y, Bes M, Lina G, Vandenesch F, Floret D, Etienne J, Richet H. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 2002, 35:819-824. 10.1086/342576, 12228818.
7. Bocchini CE, Hulten KG, Mason EO, Gonzalez BE, Hammerman WA, Kaplan SL. Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute Staphylococcus aureus osteomyelitis in children. Pediatrics 2006, 117:433-440. 10.1542/peds.2005-0566, 16452363.
8. Martinez-Aguilar G, Hammerman WA, Mason EO, Kaplan SL. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J 2003, 22:593-598. 10.1097/00006454-200307000-00006, 12867833.
9. Hyun DY, Mason EO, Forbes A, Kaplan SL. Trimethoprim-sulfamethoxazole or clindamycin for treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatr Infect Dis J 2009, 28:57-59. 10.1097/INF.0b013e3181826e5e, 19057459.
10. Mongkolrattanothai K, Aldag JC, Mankin P, Gray BM. Epidemiology of community-onset Staphylococcus aureus infections in pediatric patients: an experience at a Children's Hospital in central Illinois. BMC Infect Dis 2009, 9:112. 10.1186/1471-2334-9-112, 2722661, 19607683.
11. Aires de Sousa M, Bartzavali C, Spiliopoulou I, Santos Sanches I, Crisóstomo MI, de Lencastre H. Two international methicillin-resistant Staphylococcus aureus clones endemic in a university hospital in Patras, Greece. J Clin Microbiol 2003, 41:2027-2032. 10.1128/JCM.41.5.2027-2032.2003, 154747, 12734244.
12. Chini V, Petinaki E, Foka A, Paratiras S, Dimitracopoulos G, Spiliopoulou I. Spread of Staphylococcus aureus clinical isolates carrying Panton-Valentine leukocidin genes during a 3-year period in Greece. Clin Microbiol Infect 2006, 12:29-34. 10.1111/j.1469-0691.2005.01295.x, 16460543.
13. Nathwani D, Morgan M, Masterton RG, Dryden M, Cookson BD, French GL, Lewis D, . British Society for Antimicrobial Chemotherapy Working Party on Community-onset MRSA Infections Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chemother 2008, 61:976-994. 10.1093/jac/dkn096, 18339633, British Society for Antimicrobial Chemotherapy Working Party on Community-onset MRSA Infections.
14. Clinical and Laboratory Standards Institute, CLSI M02-A10. Performance standards for antimicrobial disk susceptibility tests; tenth edition. 2009, CLSI: Wayne PA-USA, Clinical and Laboratory Standards Institute, CLSI.
15. Clinical and Laboratory Standards Institute, CLSI M100-S20. Performance standards for antimicrobial susceptibility testing; 20th informational supplement. 2009, CLSI: Wayne PA-USA, Clinical and Laboratory Standards Institute, CLSI.
16. The European Committee on Antimicrobial Susceptibility Testing (EUCAST) Breakpoint tables for interpretations of MICs and zone diameters. Version 1.1, April 2010. The European Committee on Antimicrobial Susceptibility Testing (EUCAST)., http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Disk_test_documents/EUCAST_breakpoints_v1.1.pdf
17. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000, 38:1008-1015. 86325, 10698988.
18. Tristan A, Bes M, Meugnier H, Lina G, Bozdogan B, Courvalin P, Reverdy ME, Enright MC, Vandenesch F, Etienne J. Global distribution of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis 2007, 13:594-600. 10.3201/eid1304.061316, 2725977, 17553275.
19. Otter JA, French GL. Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe. Lancet Infect Dis 2010, 10:227-239. 10.1016/S1473-3099(10)70053-0, 20334846.
20. Ben Nejma M, Mastouri M, Bel Hadj Jrad B, Nour M. Characterization of ST80 Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus clone in Tunisia. Diagn Microbiol Infect Dis 2008,
21. Adler A, Givon-Lavi N, Moses AE, Block C, Dagan R. Carriage of community-associated methicillin-resistant Staphylococcus aureus in a cohort of infants in Southern Israel: risk factors and molecular features. J Clin Microbiol 2010, 48:531-538. 10.1128/JCM.02290-08, 2815591, 20007386.
22. Crémieux AC, Dumitrescu O, Lina G, Vallee C, Côté JF, Muffat-Joly M, Lilin T, Etienne J, Vandenesch F, Saleh-Mghir A. Panton-Valentine leukocidin enhances the severity of community-associated methicillin-resistant Staphylococcus aureus rabbit osteomyelitis. PLoS One 2009, 4:e7204. 10.1371/journal.pone.0007204, 2744873, 19779608.
23. Wang R, Braughton KR, Kretschmer D, Bach TH, Queck SY, Li M, Kennedy AD, Dorward DW, Klebanoff SJ, Peschel A, DeLeo FR, Otto M. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 2007, 13:1510-1514. 10.1038/nm1656, 17994102.
24. Kaplan SL, Hulten KG, Hammerman WA, Lamberth L, Versalovic J, Mason EO. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005, 40:1785-91. 10.1086/430312, 15909267.
25. Fortunov RM, Hulten KG, Hammerman WA, Mason EO, Kaplan SL. Previously healthy neonates community-acquired Staphylococcus aureus infections in term and near-term. Pediatrics 2006, 118:874-881. 10.1542/peds.2006-0884, 16950976.
26. O'Neill AJ, Larsen AR, Skov R, Henriksen AS, Chopra I. Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus. J Clin Microbiol 2007, 45:1505-1510. 10.1128/JCM.01984-06, 1865894, 17344365.
27. O'Neill AJ, McLaws F, Kahlmeter G, Henriksen AS, Chopra I. Genetic basis of resistance to fusidic acid in staphylococci. Antimicrob Agents Chemother 2007, 51:1737-1740. 10.1128/AAC.01542-06, 1855526, 17325218.
28. Lannergård J, Norström T, Hughes D. Genetic determinants of resistance to fusidic acid among clinical bacteremia isolates of Staphylococcus aureus. Antimicrob Agents Chemother 2009, 53:2059-2065. 10.1128/AAC.00871-08, 2681530, 19289529.
29. Salmenlinna S, Lyytikäinen O, Vuopio-Varkila J. Community-acquired methicillin-resistant Staphylococcus aureus, Finland. Emerg Infect Dis 2002, 8:602-607. 2738488, 12023917.
30. Denis O, Deplano A, De Beenhouwer H, Hallin M, Huysmans G, Garrino MG, Glupczynski Y, Malaviolle X, Vergison A, Struelens MJ. Polyclonal emergence and importation of community-acquired methicillin-resistant Staphylococcus aureus strains harbouring Panton-Valentine leucocidin genes in Belgium. J Antimicrob Chemother 2005, 56:1103-1106. 10.1093/jac/dki379, 16223937.
31. Wannet W, Spalburg E, Heck ME, Pluister GN, Tiemersma E, Willems RJ, Huijsdens XW, de Neeling AJ, Etienne J. Emergence of virulent MRSA strains containing the Panton Valentine leukocidin genes in the Netherlands. J Clin Microbiol 2005, 43:3341-3345. 10.1128/JCM.43.7.3341-3345.2005, 1169179, 16000458.
32. Witte W, Braulke C, Cuny C, Strommenger B, Werner G, Heuck D, Jappe U, Wendt C, Linde H-J, Harmsen D. Emergence of methicillin-resistant Staphylococcus aureus with Panton-Valentine leukocidin genes in central Europe. Eur J Clin Microbiol Infect Dis 2005, 24:1-5. 10.1007/s10096-004-1262-x, 15599784.
33. Comité de l' Antibiogramme de la Société Française de Microbiologie Recommandations 2008 (Edition de Janvier 2008). Comité de l' Antibiogramme de la Société Française de Microbiologie., http://www.sfm.asso.fr/doc/download.php?doc=DiU8C&fic=casfm_2008.pdf
34. Jones RN, Castanheira M, Rhomberg PR, Woosley LN, Pfaller MA. Performance of fusidic acid (CEM-102) susceptibility testing reagents: broth microdilution, disk diffusion, and Etest methods as applied to Staphylococcus aureus. J Clin Microbiol 2010, 48:972-976. 10.1128/JCM.01829-09, 2832462, 20053856.
35. Livermore D, James D, Duckworth G, Stephens P. Fusidic-acid use and resistance. Lancet 2002, 360:806. 10.1016/S0140-6736(02)09921-X, 12241858.
36. Howden BP, Grayson ML. Dumb and dumber-The potential waste of a useful antistaphylococcal agent: Emerging fusidic acid resistance in Staphylococcus aureus. Clin Infect Dis 2006, 42:394-400. 10.1086/499365, 16392088.
37. Kaplan SL. Community-acquired methicillin-resistant Staphylococcus aureus infections in children. Semin Pediatr Infect Dis 2006, 17:113-119. 10.1053/j.spid.2006.06.004, 16934705.
38. Stevens DL, Ma Y, Salmi D, McIndoo E, Wallace RJ, Bryant AE. Impact of antibiotics on expression of virulence-associated exotoxin genes. J Infect Dis 2007, 195:202-211. 10.1086/510396, 17191165.
39. Siberry GK, Tekle T, Carroll K, Dick J. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis 2003, 37:1257-1260. 10.1086/377501, 14557972.
40. Daurel C, Huet C, Dhalluin A, Bes M, Etienne J, Leclercq R. Differences in potential for selection of clindamycin-resistant mutants between inducible erm(A) and erm(C) Staphylococcus aureus genes. J Clin Microbiol 2008, 46:546-550. 10.1128/JCM.01925-07, 2238126, 18077631.
41. Fergie J, Purcell K. The treatment of community-acquired methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J 2008, 27:67-68. 10.1097/INF.0b013e31816087a7, 18162942.
42. Hyun DY, Mason EO, Forbes A, Kaplan SL. Trimethoprim-sulfamethoxasole or clindamycin for treatment of community-acquired methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatr Infect Dis J 2008, 28:57-59.
43. Lee MC, Rios AM, Aten MF, Mejias A, Cavuoti D, McCracken GH, Hardy RD. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis 2004, 23:123-127. 10.1097/01.inf.0000109288.06912.21.
44. Duong M, Markwell S, Peter J, Barenkamp S. Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient. Ann Emerg Med 2010, 55:401-407. 10.1016/j.annemergmed.2009.03.014, 19409657.